China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study on the Efficacy and Safety of Zinc Sulfate Enhancing Toripalimab Combined with Axitinib in the Treatment of Advanced Renal Cell Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130070
Registration Time: 2026/08/14
Type: Interventional study
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331671
Published by HT Digital Content Services with permission from Health Daily Digest....